OncoSec Medical, Inc.
(NASDAQ : ONCS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
TDOCTeladoc Health, Inc. -4.55%25.598.2%$114.60m
DNAGinkgo Bioworks Holdings, Inc. -1.70%3.180.0%$75.73m
CANOCano Health, Inc. 6.79%9.440.0%$59.45m
DVADaVita, Inc. -1.22%87.844.3%$57.95m
ONEM1Life Healthcare, Inc. 0.00%17.080.0%$56.63m
AGLAgilon Health, Inc. -2.79%22.500.0%$56.28m
GHGuardant Health, Inc. -2.04%58.550.0%$51.19m
ACHCAcadia Healthcare Co., Inc. -2.55%80.6726.5%$47.50m
LHCGLHC Group, Inc. -0.13%164.643.0%$47.15m
OSHOak Street Health, Inc. -5.26%22.510.0%$38.63m
OPCHOption Care Health, Inc. -3.61%32.490.0%$37.73m
AMEDAmedisys, Inc. -1.53%95.6711.5%$36.11m
EHCEncompass Health Corp. -1.65%48.240.0%$33.81m
PRVAPrivia Health Group, Inc. -2.70%34.270.0%$33.04m
AZTAAzenta, Inc. -4.91%42.760.0%$30.75m

Company Profile

OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered in Pennington, NJ.